Innovation in Healthcare

Anastasia Daifotis, Chief Scientific Officer, Janssen North America Pharmaceuticals discusses disparities in health care, ways to improve the system, and why innovation matters. She also talks about what we can expect to see in our healthcare system in the next 5 – 10 years. 

Anastasia sets the medical strategy for Janssen North America and plays a key role in shaping overall business strategy. She is responsible for accelerating the development of medical and scientific capabilities essential to winning in a value-based healthcare system, such as real-world evidence and healthcare economics, and for pharmacovigilance, including Medical Information and Call Center operations. She partners closely with R&D and Global Medical Affairs leadership on product development programs and plays an important medical role in licensing and acquisitions. As leader of the Medical and Scientific Affairs Council for Janssen North America, she is responsible for shaping the medical and scientific vision for the region internally and representing Janssen externally on advisory and policy-making bodies across the region.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.